Clinical presentation and ultrasonography in the diagnosis of pancreatic cancer

A. Maringhini, M. Ciambra, Massimo Raimondo, P. Baccelliere, R. Grasso, G. Dardanoni, F. Lanzarone, M. Cottone, E. Sciarrino, L. Pagliaro

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

One thousand twenty patients consecutively admitted because of a clinical suspicion of pancreatic cancer were investigated to evaluate the accuracy of simple clinical, laboratory, and ultrasonographic data in the diagnosis of pancreatic cancer. Age, weight loss, recent-onset diabetes mellitus, palpable abdominal mass or gallbladder, elevated serum bilirubin or alkaline phosphatase levels, and ultrasonography were significant criteria in discriminating 80 pancreatic cancers from 940 controls. The most sensitive criteria were ultrasonography (83%), weight loss (66%), and bilirubin level of >3 mg/dl (61%); the most specific were ultrasonography (99%), recent- onset diabetes (97%), and a distended palpable gallbladder (94%). Only ultrasonography demonstrated an elevated positive predictive value (86%), while weight loss, elevated bilirubin and alkaline phosphatase, besides ultrasonography had an elevated negative predictive value (95%). These results show that advanced pancreatic cancer may be excluded with simple clinical and laboratory data; ultrasonography can confirm the diagnosis with a high degree of accuracy. We suggest that the results of any new diagnostic tests for pancreatic cancer be compared with these clinical findings.

Original languageEnglish (US)
Pages (from-to)146-150
Number of pages5
JournalPancreas
Volume8
Issue number2
StatePublished - 1993
Externally publishedYes

Fingerprint

Pancreatic Neoplasms
Ultrasonography
Bilirubin
Weight Loss
Gallbladder
Alkaline Phosphatase
Routine Diagnostic Tests
Diabetes Mellitus
Serum

Keywords

  • Pancreatic cancer
  • Ultrasonography

ASJC Scopus subject areas

  • Endocrinology
  • Gastroenterology

Cite this

Maringhini, A., Ciambra, M., Raimondo, M., Baccelliere, P., Grasso, R., Dardanoni, G., ... Pagliaro, L. (1993). Clinical presentation and ultrasonography in the diagnosis of pancreatic cancer. Pancreas, 8(2), 146-150.

Clinical presentation and ultrasonography in the diagnosis of pancreatic cancer. / Maringhini, A.; Ciambra, M.; Raimondo, Massimo; Baccelliere, P.; Grasso, R.; Dardanoni, G.; Lanzarone, F.; Cottone, M.; Sciarrino, E.; Pagliaro, L.

In: Pancreas, Vol. 8, No. 2, 1993, p. 146-150.

Research output: Contribution to journalArticle

Maringhini, A, Ciambra, M, Raimondo, M, Baccelliere, P, Grasso, R, Dardanoni, G, Lanzarone, F, Cottone, M, Sciarrino, E & Pagliaro, L 1993, 'Clinical presentation and ultrasonography in the diagnosis of pancreatic cancer', Pancreas, vol. 8, no. 2, pp. 146-150.
Maringhini A, Ciambra M, Raimondo M, Baccelliere P, Grasso R, Dardanoni G et al. Clinical presentation and ultrasonography in the diagnosis of pancreatic cancer. Pancreas. 1993;8(2):146-150.
Maringhini, A. ; Ciambra, M. ; Raimondo, Massimo ; Baccelliere, P. ; Grasso, R. ; Dardanoni, G. ; Lanzarone, F. ; Cottone, M. ; Sciarrino, E. ; Pagliaro, L. / Clinical presentation and ultrasonography in the diagnosis of pancreatic cancer. In: Pancreas. 1993 ; Vol. 8, No. 2. pp. 146-150.
@article{99d787e60ef94df485909c76e4f30863,
title = "Clinical presentation and ultrasonography in the diagnosis of pancreatic cancer",
abstract = "One thousand twenty patients consecutively admitted because of a clinical suspicion of pancreatic cancer were investigated to evaluate the accuracy of simple clinical, laboratory, and ultrasonographic data in the diagnosis of pancreatic cancer. Age, weight loss, recent-onset diabetes mellitus, palpable abdominal mass or gallbladder, elevated serum bilirubin or alkaline phosphatase levels, and ultrasonography were significant criteria in discriminating 80 pancreatic cancers from 940 controls. The most sensitive criteria were ultrasonography (83{\%}), weight loss (66{\%}), and bilirubin level of >3 mg/dl (61{\%}); the most specific were ultrasonography (99{\%}), recent- onset diabetes (97{\%}), and a distended palpable gallbladder (94{\%}). Only ultrasonography demonstrated an elevated positive predictive value (86{\%}), while weight loss, elevated bilirubin and alkaline phosphatase, besides ultrasonography had an elevated negative predictive value (95{\%}). These results show that advanced pancreatic cancer may be excluded with simple clinical and laboratory data; ultrasonography can confirm the diagnosis with a high degree of accuracy. We suggest that the results of any new diagnostic tests for pancreatic cancer be compared with these clinical findings.",
keywords = "Pancreatic cancer, Ultrasonography",
author = "A. Maringhini and M. Ciambra and Massimo Raimondo and P. Baccelliere and R. Grasso and G. Dardanoni and F. Lanzarone and M. Cottone and E. Sciarrino and L. Pagliaro",
year = "1993",
language = "English (US)",
volume = "8",
pages = "146--150",
journal = "Pancreas",
issn = "0885-3177",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Clinical presentation and ultrasonography in the diagnosis of pancreatic cancer

AU - Maringhini, A.

AU - Ciambra, M.

AU - Raimondo, Massimo

AU - Baccelliere, P.

AU - Grasso, R.

AU - Dardanoni, G.

AU - Lanzarone, F.

AU - Cottone, M.

AU - Sciarrino, E.

AU - Pagliaro, L.

PY - 1993

Y1 - 1993

N2 - One thousand twenty patients consecutively admitted because of a clinical suspicion of pancreatic cancer were investigated to evaluate the accuracy of simple clinical, laboratory, and ultrasonographic data in the diagnosis of pancreatic cancer. Age, weight loss, recent-onset diabetes mellitus, palpable abdominal mass or gallbladder, elevated serum bilirubin or alkaline phosphatase levels, and ultrasonography were significant criteria in discriminating 80 pancreatic cancers from 940 controls. The most sensitive criteria were ultrasonography (83%), weight loss (66%), and bilirubin level of >3 mg/dl (61%); the most specific were ultrasonography (99%), recent- onset diabetes (97%), and a distended palpable gallbladder (94%). Only ultrasonography demonstrated an elevated positive predictive value (86%), while weight loss, elevated bilirubin and alkaline phosphatase, besides ultrasonography had an elevated negative predictive value (95%). These results show that advanced pancreatic cancer may be excluded with simple clinical and laboratory data; ultrasonography can confirm the diagnosis with a high degree of accuracy. We suggest that the results of any new diagnostic tests for pancreatic cancer be compared with these clinical findings.

AB - One thousand twenty patients consecutively admitted because of a clinical suspicion of pancreatic cancer were investigated to evaluate the accuracy of simple clinical, laboratory, and ultrasonographic data in the diagnosis of pancreatic cancer. Age, weight loss, recent-onset diabetes mellitus, palpable abdominal mass or gallbladder, elevated serum bilirubin or alkaline phosphatase levels, and ultrasonography were significant criteria in discriminating 80 pancreatic cancers from 940 controls. The most sensitive criteria were ultrasonography (83%), weight loss (66%), and bilirubin level of >3 mg/dl (61%); the most specific were ultrasonography (99%), recent- onset diabetes (97%), and a distended palpable gallbladder (94%). Only ultrasonography demonstrated an elevated positive predictive value (86%), while weight loss, elevated bilirubin and alkaline phosphatase, besides ultrasonography had an elevated negative predictive value (95%). These results show that advanced pancreatic cancer may be excluded with simple clinical and laboratory data; ultrasonography can confirm the diagnosis with a high degree of accuracy. We suggest that the results of any new diagnostic tests for pancreatic cancer be compared with these clinical findings.

KW - Pancreatic cancer

KW - Ultrasonography

UR - http://www.scopus.com/inward/record.url?scp=0027474927&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027474927&partnerID=8YFLogxK

M3 - Article

C2 - 8460088

AN - SCOPUS:0027474927

VL - 8

SP - 146

EP - 150

JO - Pancreas

JF - Pancreas

SN - 0885-3177

IS - 2

ER -